☆ 4.7 Article

Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

NEUROLOGY (2013)

Get Full Text
Add to Collection

Journal

NEUROLOGY
Volume 81, Issue 24, Pages 2136-2140

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000437305.37850.f9

Keywords

-

Categories

Clinical Neurology

Funding

  1. Muscular Dystrophy Association
  2. AB Science
  3. Acorda
  4. ALS Therapy Alliance
  5. Asubio
  6. Avanir
  7. Biogen Idec
  8. Bristol-Myers Squibb
  9. Cytokinetics
  10. GlaxoSmithKline
  11. Knopp Bioscience
  12. Neuraltus
  13. National Institute of Neurological Disorders and Stroke Clinical Research Consortium
  14. NHLBI/NIH [R01HL103676-01A1 NIH/NHLBI, R01HL093081 NIH/NHLBI]
  15. Knopp Pharmaceuticals
  16. ATSDR

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.